Adempas®/Riociguat
Manufactured by:
Bayer
Programs
Co-pay Assistance Program:
- Co-pay Assistance Program helps reduce eligible individuals’ out-of-pocket responsibility by providing up to 100% coverage of co-pays or coinsurance directly to the insurer.
Patients must have private commercial insurance with a percentage coinsurance or co-pay requirement. Medicare or Medicaid patients are ineligible. Assistance is for one year, after which, patients must re-apply. Patients must notify the program of any change in their insurance status. Patients in certain states may be ineligible. The co-pay assistance program has an annual cap per patient year.
Temporary Patient Assistance Program (TPAP):
- TPAP can help in some temporary situations when immediate coverage is not available. For example, waiting for approval of a prior authorization appeal, waiting for coverage to begin, etc.
Serves individuals who are uninsured (no insurance coverage at all) or underinsured (no prescription coverage, a benefits cap, denial of coverage, etc.)
Patient Assistance Program (PAP):
- PAP provides eligible individuals with medication free of cost for one year from the date of acceptance. Medicare Part D patients will be enrolled based on calendar year if eligible.
Serves individuals who are uninsured or underinsured (when criteria are met and alternative funding cannot be identified.)
Additional Resources:
Aim also provides 24/7 nursing support by phone and at-home nurse visits at the recommendation of a physician.
Contact Information
For more information, call toll-free:
1-855-4ADEMPAS (1-855-423-3672)
Learn more about the Aim Patient Support Program